Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00304330 · ClinicalTrials.gov registry record
Emergence of Gram-negative Resistance in Blood Culture Isolates of Solid-organ Transplant Recipients
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 1,000
- Enrollment target
NCT00304330 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 1,000 participants.
The verdict
NCT00304330 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
The information collected will provide insight in to the epidemiology of antibiotic resistance in a transplant compared to a non-transplant population. Data is needed regarding the date of admission, date of bloodstream infection and location of ward/ICU so trends in the emergence of resistance and antibiotic usage can be detected.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2006-09 |
| Est. Completion | 2017-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00304330
The ClinicalTrials.gov registry entry for NCT00304330 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00304330 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00304330 about?
NCT00304330 is a clinical study titled "Emergence of Gram-negative Resistance in Blood Culture Isolates of Solid-organ Transplant Recipients". The information collected will provide insight in to the epidemiology of antibiotic resistance in a transplant compared to a non-transplant population. Data is needed regarding the date of admission, date of bloodstream infection and location of ward/ICU so trends in the emergence of resistance and ...
What is the current status of trial NCT00304330?
This trial is currently completed. The enrollment target is 1,000 participants. The study started on 2006-09. Estimated completion is 2017-06.
Who is sponsoring clinical trial NCT00304330?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.